当前位置: 阿仪网 > 上海陶术生物科技有限公司 > 产品展示 > 药物筛选分子库 > Mini片段亲电杂环库
Mini片段亲电杂环库
企业档案
会员类型:至尊版
已获得阿仪网信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
阿仪网至尊版会员:7年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
参观次数:7001726
详细内容
Since screening electrophilic fragments has become a promising alternative to discovering and verifying new targets and generating viable chemical starting points, we designed a Mini Electrophilic Heterocyclic Fragment Library. These compounds are basically covalent MiniFrags, containing five- and six-membered nitrogen-containing heterocycles with electron-withdrawing properties that can activate small electrophilic substituents (halogen, ethynyl, vinyl, and nitrile groups). The library contains not only small electrophilic heterocycles, but also N-quaternized analogs with increased reactivity. 371 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library
Product Description
The theoretical basis of FBDD is to select favorable fragment combinations or extensions to obtain new drug molecules, with a higher probability of obtaining highly active drug candidates. Compared with the screening of millions of macromolecules, thousands of fragment molecules can be combined to form millions of drug structures, which are easier to collect and manage. In addition, fragments have smaller molecular weights, relatively higher solubility, and easier structural optimization. The potential of over-the-counter medicine is higher. Targeted covalent inhibitors and chemical probes have become part of drug discovery methods. Given the advantages of fragment-based drug discovery, screening electrophilic fragments has become a promising alternative to discover and verify new targets and generate viable chemical starting points, even for targets that are almost difficult to handle. In response to this situation, we designed a small library of heterocyclic electrophilic compounds.
General technology for covalent fragment screening :

化合物库定制
我们的化合物库可以灵活定制! 了解更多品牌介绍:
TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化域科学家的研究提供业的产品和服务。TargetMol品牌的客户群分布于40多个国家和地区,已发展成为全球大的化合物库和小分子化合物研究供应商之一。
☆ 产品适应在癌症、免疫学、心血管系统、呼吸、神经科学等多项科学域的研发使用,超过1180万种小分子化合物。
☆ 提供20000多个小分子抑制剂、天然产物和200多个化合物库。
☆ 配备完善的化学合成和生物实验室,可分别提供高品质小分子抑制剂和药物筛选技术服务。
☆ 每批产品都有严格的NMR和HPLC技术检测,以保证产品高纯度高质量。
热门标签:片段,药物筛选,分子库,药物,,靶点

















